Canada · Delayed Price · Currency is CAD Extendicare Statistics
Total Valuation
Extendicare has a market cap or net worth of CAD 1.35 billion. The enterprise value is 1.56 billion.
| Market Cap | 1.35B |
| Enterprise Value | 1.56B |
Important Dates
The next estimated earnings date is Tuesday, November 11, 2025.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | Oct 31, 2025 |
Share Statistics
Extendicare has 83.82 million shares outstanding. The number of shares has increased by 7.21% in one year.
| Current Share Class | 83.82M |
| Shares Outstanding | 83.82M |
| Shares Change (YoY) | +7.21% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | 1.28% |
| Owned by Institutions (%) | 33.37% |
| Float | 82.55M |
Valuation Ratios
The trailing PE ratio is 16.81 and the forward PE ratio is 16.44.
| PE Ratio | 16.81 |
| Forward PE | 16.44 |
| PS Ratio | 0.89 |
| PB Ratio | 9.05 |
| P/TBV Ratio | 40.87 |
| P/FCF Ratio | 17.08 |
| P/OCF Ratio | 10.26 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.07, with an EV/FCF ratio of 19.75.
| EV / Earnings | 18.75 |
| EV / Sales | 1.03 |
| EV / EBITDA | 11.07 |
| EV / EBIT | 12.94 |
| EV / FCF | 19.75 |
Financial Position
The company has a current ratio of 0.85, with a Debt / Equity ratio of 1.91.
| Current Ratio | 0.85 |
| Quick Ratio | 0.54 |
| Debt / Equity | 1.91 |
| Debt / EBITDA | 2.03 |
| Debt / FCF | 3.60 |
| Interest Coverage | 6.50 |
Financial Efficiency
Return on equity (ROE) is 65.09% and return on invested capital (ROIC) is 17.31%.
| Return on Equity (ROE) | 65.09% |
| Return on Assets (ROA) | 10.10% |
| Return on Invested Capital (ROIC) | 17.31% |
| Return on Capital Employed (ROCE) | 25.99% |
| Revenue Per Employee | 64,201 |
| Profits Per Employee | 3,540 |
| Employee Count | 23,000 |
| Asset Turnover | 2.03 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Extendicare has paid 26.53 million in taxes.
| Income Tax | 26.53M |
| Effective Tax Rate | 24.18% |
Stock Price Statistics
The stock price has increased by +76.32% in the last 52 weeks. The beta is 1.30, so Extendicare's price volatility has been higher than the market average.
| Beta (5Y) | 1.30 |
| 52-Week Price Change | +76.32% |
| 50-Day Moving Average | 14.00 |
| 200-Day Moving Average | 13.12 |
| Relative Strength Index (RSI) | 78.01 |
| Average Volume (20 Days) | 172,533 |
Short Selling Information
The latest short interest is 1.59 million, so 1.90% of the outstanding shares have been sold short.
| Short Interest | 1.59M |
| Short Previous Month | 1.60M |
| Short % of Shares Out | 1.90% |
| Short % of Float | 2.22% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Extendicare had revenue of CAD 1.51 billion and earned 83.18 million in profits. Earnings per share was 0.96.
| Revenue | 1.51B |
| Gross Profit | 211.74M |
| Operating Income | 119.91M |
| Pretax Income | 109.71M |
| Net Income | 83.18M |
| EBITDA | 136.30M |
| EBIT | 119.91M |
| Earnings Per Share (EPS) | 0.96 |
Balance Sheet
The company has 72.62 million in cash and 284.12 million in debt, giving a net cash position of -211.50 million or -2.52 per share.
| Cash & Cash Equivalents | 72.62M |
| Total Debt | 284.12M |
| Net Cash | -211.50M |
| Net Cash Per Share | -2.52 |
| Equity (Book Value) | 148.91M |
| Book Value Per Share | 1.78 |
| Working Capital | -48.48M |
Cash Flow
In the last 12 months, operating cash flow was 131.43 million and capital expenditures -52.49 million, giving a free cash flow of 78.93 million.
| Operating Cash Flow | 131.43M |
| Capital Expenditures | -52.49M |
| Free Cash Flow | 78.93M |
| FCF Per Share | 0.94 |
Margins
Gross margin is 14.03%, with operating and profit margins of 7.95% and 5.51%.
| Gross Margin | 14.03% |
| Operating Margin | 7.95% |
| Pretax Margin | 7.27% |
| Profit Margin | 5.51% |
| EBITDA Margin | 9.03% |
| EBIT Margin | 7.95% |
| FCF Margin | 5.23% |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 3.15%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 3.15% |
| Dividend Growth (YoY) | 3.33% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 48.82% |
| Buyback Yield | -7.21% |
| Shareholder Yield | -4.06% |
| Earnings Yield | 6.17% |
| FCF Yield | 5.86% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Extendicare has an Altman Z-Score of 2.65 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.65 |
| Piotroski F-Score | 7 |